BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31375726)

  • 1. Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?
    Li Y; Sperrin M; Belmonte M; Pate A; Ashcroft DM; van Staa TP
    Sci Rep; 2019 Aug; 9(1):11222. PubMed ID: 31375726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.
    Li Y; Sperrin M; Ashcroft DM; van Staa TP
    BMJ; 2020 Nov; 371():m3919. PubMed ID: 33148619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease.
    Li Y; Sperrin M; Martin GP; Ashcroft DM; van Staa TP
    Int J Med Inform; 2020 Jan; 133():104033. PubMed ID: 31785526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
    Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
    Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.
    Pate A; Emsley R; Ashcroft DM; Brown B; van Staa T
    BMC Med; 2019 Jul; 17(1):134. PubMed ID: 31311543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
    Livingstone SJ; Guthrie B; Donnan PT; Thompson A; Morales DR
    BMC Med; 2022 May; 20(1):152. PubMed ID: 35505353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
    van Staa TP; Gulliford M; Ng ES; Goldacre B; Smeeth L
    PLoS One; 2014; 9(10):e106455. PubMed ID: 25271417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
    Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
    Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.
    Hageman SHJ; Dorresteijn JAN; Pennells L; van Smeden M; Bots ML; Di Angelantonio E; Visseren FLJ
    Eur J Prev Cardiol; 2023 Nov; 30(16):1741-1747. PubMed ID: 37338108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency of ranking was evaluated as new measure for prediction model stability: longitudinal cohort study.
    Li Y; Sperrin M; Ashcroft DM; van Staa TP
    J Clin Epidemiol; 2021 Oct; 138():168-177. PubMed ID: 34224835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model.
    Dhana K; Ikram MA; Hofman A; Franco OH; Kavousi M
    Heart; 2015 Mar; 101(5):377-83. PubMed ID: 25502814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Lato V; Becciolini A; Favalli EG; Giovagnoni A
    Swiss Med Wkly; 2018 Aug; 148():w14656. PubMed ID: 30141517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and validation of a cardiovascular disease risk-prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT).
    Manuel DG; Tuna M; Bennett C; Hennessy D; Rosella L; Sanmartin C; Tu JV; Perez R; Fisher S; Taljaard M
    CMAJ; 2018 Jul; 190(29):E871-E882. PubMed ID: 30037888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study.
    Warren-Gash C; Davidson JA; Strongman H; Herrett E; Smeeth L; Breuer J; Banerjee A
    Lancet Reg Health Eur; 2023 Apr; 27():100604. PubMed ID: 36911072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
    Friis-Møller N; Ryom L; Smith C; Weber R; Reiss P; Dabis F; De Wit S; Monforte AD; Kirk O; Fontas E; Sabin C; Phillips A; Lundgren J; Law M;
    Eur J Prev Cardiol; 2016 Jan; 23(2):214-23. PubMed ID: 25882821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project.
    Hata J; Nagai A; Hirata M; Kamatani Y; Tamakoshi A; Yamagata Z; Muto K; Matsuda K; Kubo M; Nakamura Y; ; Kiyohara Y; Ninomiya T
    J Epidemiol; 2017 Mar; 27(3S):S71-S76. PubMed ID: 28142037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.